Is PharmaResearch Co., Ltd. (KOSDAQ:214450) Trading At A 25% Discount?
May 27
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthcare Sector Analysis
UpdatedJun 06, 2025
DataAggregated Company Financials
Companies365
- 7D0.1%
- 3M-2.3%
- 1Y15.7%
- YTD5.3%
Over the last 7 days, the Healthcare industry has remained flat, although notably ALTEOGEN gained 10%. As for the the longer term, the industry is up 16% over the past 12 months. Looking forward, earnings are forecast to grow by 29% annually.
Sector Valuation and Performance
Has the South Korean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 06 Jun 2025 | ₩270.9t | ₩57.6t | ₩1.5t | 21.6x | 175.8x | 4.7x |
| Sun, 04 May 2025 | ₩270.8t | ₩56.1t | ₩1.4t | 18.6x | 198.6x | 4.8x |
| Tue, 01 Apr 2025 | ₩256.0t | ₩55.9t | ₩1.1t | 17.3x | 243.6x | 4.6x |
| Thu, 27 Feb 2025 | ₩288.2t | ₩54.8t | ₩836.8b | 15.2x | 344.3x | 5.3x |
| Sat, 25 Jan 2025 | ₩271.7t | ₩54.6t | ₩831.2b | 15.1x | 326.8x | 5x |
| Mon, 23 Dec 2024 | ₩249.4t | ₩54.4t | ₩802.1b | 13.9x | 310.9x | 4.6x |
| Wed, 20 Nov 2024 | ₩248.9t | ₩53.2t | ₩910.6b | 15.2x | 273.4x | 4.7x |
| Fri, 18 Oct 2024 | ₩280.0t | ₩53.3t | ₩854.8b | 18x | 327.5x | 5.3x |
| Sun, 15 Sep 2024 | ₩264.8t | ₩53.4t | ₩856.4b | 17.3x | 309.2x | 5x |
| Tue, 13 Aug 2024 | ₩261.7t | ₩52.3t | ₩756.6b | 16.4x | 345.9x | 5x |
| Thu, 11 Jul 2024 | ₩245.4t | ₩52.3t | ₩750.8b | 16.6x | 326.8x | 4.7x |
| Sat, 08 Jun 2024 | ₩231.9t | ₩52.9t | ₩737.2b | 16.3x | 314.6x | 4.4x |
| Mon, 06 May 2024 | ₩234.9t | ₩52.3t | ₩545.6b | 18.4x | 430.6x | 4.5x |
| Wed, 03 Apr 2024 | ₩238.2t | ₩52.3t | ₩463.2b | 18.1x | 514.2x | 4.6x |
| Fri, 01 Mar 2024 | ₩226.1t | ₩52.0t | -₩48,458,490,006.00 | 21.9x | -4665x | 4.3x |
| Sun, 28 Jan 2024 | ₩236.4t | ₩55.7t | ₩55.5b | 22.9x | 4262.6x | 4.2x |
| Tue, 26 Dec 2023 | ₩221.8t | ₩56.1t | ₩267.5b | 21.7x | 829.1x | 4x |
| Thu, 23 Nov 2023 | ₩210.7t | ₩55.9t | ₩350.3b | 19.3x | 601.4x | 3.8x |
| Sat, 21 Oct 2023 | ₩192.1t | ₩56.0t | ₩1.0t | 17x | 187.6x | 3.4x |
| Mon, 18 Sep 2023 | ₩216.9t | ₩56.0t | ₩933.2b | 20.5x | 232.4x | 3.9x |
| Wed, 16 Aug 2023 | ₩221.6t | ₩56.1t | ₩2.1t | 23x | 106x | 3.9x |
| Fri, 14 Jul 2023 | ₩206.5t | ₩56.1t | ₩2.1t | 20.8x | 98.1x | 3.7x |
| Sun, 11 Jun 2023 | ₩217.9t | ₩56.3t | ₩2.1t | 22.1x | 103.3x | 3.9x |
| Tue, 09 May 2023 | ₩214.6t | ₩58.4t | ₩3.2t | 20.9x | 66x | 3.7x |
| Thu, 06 Apr 2023 | ₩209.6t | ₩58.3t | ₩3.2t | 20.3x | 64.5x | 3.6x |
| Sat, 04 Mar 2023 | ₩203.2t | ₩57.8t | ₩4.6t | 19.4x | 44.2x | 3.5x |
| Mon, 30 Jan 2023 | ₩207.7t | ₩57.8t | ₩4.6t | 16.8x | 45.1x | 3.6x |
| Wed, 28 Dec 2022 | ₩208.9t | ₩58.0t | ₩4.4t | 16.1x | 47.9x | 3.6x |
| Fri, 25 Nov 2022 | ₩213.3t | ₩57.0t | ₩4.1t | 15.6x | 51.4x | 3.7x |
| Sun, 23 Oct 2022 | ₩194.5t | ₩55.7t | ₩4.1t | 14.7x | 47.7x | 3.5x |
| Tue, 20 Sep 2022 | ₩203.1t | ₩54.8t | ₩3.8t | 17.6x | 53.6x | 3.7x |
| Thu, 18 Aug 2022 | ₩232.2t | ₩54.2t | ₩3.9t | 21.2x | 60.3x | 4.3x |
| Sat, 16 Jul 2022 | ₩223.3t | ₩54.2t | ₩3.9t | 20.2x | 57.5x | 4.1x |
| Mon, 13 Jun 2022 | ₩220.4t | ₩54.2t | ₩3.9t | 21.9x | 56.4x | 4.1x |
Price to Earnings Ratio
56.4x
Current Industry PE
- Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 176x which is lower than its 3-year average PE of 254x.
- The 3-year average PS ratio of 4.2x is lower than the industry's current PS ratio of 4.7x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 27% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare sector?
| KR Market | 3.24% | |
| Healthcare | 0.12% | |
| Biotech | 2.74% | |
| Healthcare Services | 1.22% | |
| Healthtech | 1.22% | |
| Pharma | 0.23% | |
| Medical Equipment | -0.75% | |
| Life Sciences | -2.83% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 103x.
- Analysts are expecting annual earnings growth of 15.6%, which is lower than the prior year's growth of 42.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 68% over the next 5 years.
- This is better than its past earnings growth rate of 41% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A196170 ALTEOGEN | ₩368.50k | 10.2% +₩1.8t | 54.8% | PE158.2x | |
| A068270 Celltrion | ₩163.10k | 2.8% +₩935.6b | -10.0% | PE68.1x | |
| A214450 PharmaResearch | ₩479.00k | 8.1% +₩374.0b | 275.1% | PE44.8x | |
| A302440 SK bioscienceLtd | ₩46.15k | 6.8% +₩231.2b | -12.6% | PS9x | |
| A069620 Daewoong Pharmaceutical | ₩160.60k | 10.8% +₩180.6b | 47.9% | PE48x |
